“DESENVOLVIMENTO DE DIABETES TIPO II APARTIR DO USO PROLONGADO DE GLICOCORTICOIDES NO TRATAMENTO DA COVID-19”. REMUNOM 1, no. 1 (July 25, 2023). Accessed April 12, 2026. https://remunom.ojsbr.com/multidisciplinar/article/view/542.